Ticker LaunchRegulation A · Tier 2
Facible BioDiagnostics, Inc.
Facible BioDiagnostics, Inc. filed a Tier 2 Regulation A offering statement (Form 1-A) on May 9, 2022 for up to $40M at $5.80 per security. The SEC qualified the offering on Jul 28, 2022.
- Status
- Qualified
- Tier
- Tier 2
- Offering size
- $40M
- Offer price
- $5.80
- Security type
- Equity (common or preferred stock)
- Filed
- May 9, 2022
- Qualified
- Jul 28, 2022
- Industry
- Services-Medical Laboratories
- State
- ID
More on this offering for subscribers
- Revenue, net income and total assets from the offering statement
- Employees
- Market cap at the offer price
- Auditor
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Offering statement (Form 1-A) May 9, 2022
- All filings on EDGAR CIK 1910594
Other qualified Healthcare Reg A offerings
- ETHEMA HEALTH CorpNov 18, 2022 · $5M
- DNALabs Canada Inc.Oct 21, 2022 · $1000K
- McGinley Orthopaedic Innovations, Inc.Sep 13, 2022 · $40M
- Virtuoso Surgical, Inc.Sep 6, 2022 · $20M
- LiveCare, Inc.Jul 6, 2022 · $10M
- Medical 21, Inc.Apr 27, 2022 · $40M